Despite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.
Emma Waldon, RN
Advertisement
Registered nurse, Georgetown University, in Washington, DC
Articles by Emma Waldon, RN
Advertisement
Latest Updated Articles
Promising Disease-Modifying Therapies in Parkinson DiseasePublished: April 19th 2023 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Reverses Course on AMT-130, Citing Insufficient External Data for Submission
2
Real-World Meta-Analysis Confirms Efficacy and Safety of CGRP Treatment Galcanezumab in Migraine
3
GLP-1 Semaglutide Fails to Outperform Placebo in Phase 3 EVOKE Trial of Alzheimer Disease
4
NeurologyLive® Friday 5 — November 28, 2025
5
